The Tympanostomy Products Market to Witness Robust Growth in North America and Europe

Tympanostomy products, such as tympanostomy tubes, are used to treat inflammatory diseases of the middle ear, such as otitis media with effusion and acute otitis media. Otitis media with effusion is a condition in which there is fluid in the middle ear, but no signs of acute infection.

While, acute otitis media occurs when the area behind the middle ear becomes inflamed and infected. Thus, with the increasing prevalence of ear infection such as otitis media and otitis media with effusion, the demand for tympanostomy products is also increasing with a rapid pace. Acute otitis media is the most common condition for which medical care is provided in children under five years of age in the United States.

Worldwide, acute otitis media affects around 11% of people a year (about 325 to 710 million cases) with half occurring in those below five years. It is more common among males. Of those affected about 4.8% or 31 million develop chronic suppurative otitis media. This in turn is expected to augment the growth of the tympanostomy products market, as well as expected to increase demand for tympanostomy products worldwide.

Request Sample Copy @ https://www.coherentmarketinsights.com/market-insight/tympanostomy-products-market-3021

For example, in June 2021, Preceptis Medical announced the launch of their next-generation Hummingbird Tympanostomy Tube System (TTS) for office-based pediatric ear tube procedures.
The next-generation Hummingbird device features an enhanced ergonomic design that allows for a more efficient ear tube delivery in children.

A tympanostomy is a surgical procedure in which a surgical opening is made in the eardrum, or tympanic membrane, to promote drainage of infected fluid from the middle ear and tympanostomy tubes are implanted surgically into the eardrum to promote ongoing drainage. Tympanostomy tubes are tiny cylinders, usually made of plastic or metal, that are inserted surgically into the eardrum.

An ear tube creates an airway that ventilates the middle ear and prevents the accumulation of fluids behind the eardrum.

The aforementioned factors are also expected to accelerate the growth of the tympanostomy products market. Tympanostomy products are the primary surgical intervention for the otitis media. This is a worldwide common health problem, especially in pediatrics. In North America and Europe, the tympanostomy products market is expected to witness robust growth due to the increasing approval of tympanostomy products by regulatory authorities. In May 2020, Smith+Nephew launched FDA-approved Tula System, an in-office solution for placement of tympanostomy tubes (commonly known as ear tubes).

Talk to Analyst@ https://www.coherentmarketinsights.com/insight/talk-to-analyst/3021

The Tula System gives ENT surgeons an option to place ear tubes in an awake child during an office visit without the need for general anesthesia.

203, 2nd Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India

Coherent Market Insights (CMI) is a global market intelligence and consulting organization focused on assisting plethora of clients achieve transformational growth by helping them make critical business decisions. The company is headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan.

This release was published on openPR.